Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to $15.2 million.

  • Icu Medical's Share-based Compensation rose 2950.72% to $15.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.4 million, marking a year-over-year increase of 2074.32%. This contributed to the annual value of $46.9 million for FY2024, which is 1558.07% up from last year.
  • Icu Medical's Share-based Compensation amounted to $15.2 million in Q3 2025, which was up 2950.72% from $14.5 million recorded in Q2 2025.
  • In the past 5 years, Icu Medical's Share-based Compensation ranged from a high of $15.2 million in Q3 2025 and a low of $6.0 million during Q1 2021
  • Its 5-year average for Share-based Compensation is $10.1 million, with a median of $10.7 million in 2023.
  • Its Share-based Compensation has fluctuated over the past 5 years, first soared by 10079.71% in 2022, then plummeted by 2426.4% in 2023.
  • Quarter analysis of 5 years shows Icu Medical's Share-based Compensation stood at $8.1 million in 2021, then decreased by 8.35% to $7.4 million in 2022, then soared by 43.85% to $10.7 million in 2023, then grew by 17.15% to $12.5 million in 2024, then increased by 21.78% to $15.2 million in 2025.
  • Its last three reported values are $15.2 million in Q3 2025, $14.5 million for Q2 2025, and $12.2 million during Q1 2025.